Size Exclusion Chromatography- Based Identification of Liraglutide Oligomeric Forms

Agilent biopharma solutions Complete Analytical Workflows for GLP-1 Receptor Agonists Applications for peptide characterization, purification, and bioanalysis Contents Introduction 03 1 Identity, Purity, and Impurity Assessment 06 1.1 1.2 Introduction  Molecular Weight Confirmation of a Peptide Using MS Spectral…

Workflow Solutions for Peptide Therapeutics Application Compendium Table of Contents Introduction4 An emerging class of peptide therapeutics: GLP-15 Analytical advances in peptide therapeutics5 Key analyses for synthetic and recombinant peptide therapeutics 6 Types of impurities in peptide therapeutics 7 Agilent…

Poster Reprint ASMS 2026 WP 604 LC/MS Characterization of GLP-1 Receptor Agonist Oligomers and Other Elusive Impurities Rachel Franklin Agilent Technologies, Inc., Corvallis, OR, US Introduction Experimental GLP-1 receptor agonists (GLP-1 RAs) are peptide therapeutics that can form impurities during…

Agilent biopharma solutions Workflows for GLP-1 Receptor Agonists and Therapeutic Peptides: Identity, Impurity, Bioanalysis, and Stability Testing Contents Raw Material Purity and Impurity Identification Analysis Bioanalysis Stability Testing Studies Contents Introduction 02 1 Raw Material Identification 03 1.1 Verification…